Can platelet count be controlled with ticagrelor in patients with essential thrombocythaemia? A case series.

Samet Yılmaz Yakup Çetinkaya Hasan Akkaya Arif Arısoy

Published in: European heart journal. Case reports (2023)

Platelet counts returned to the normal range with ticagrelor treatment given after ACS in patients with JAK+ ET. Monitoring platelet reduction in JAK+ patients with P2Y12 inhibition is thought to be important for new treatment options.

Keyphrases

acute coronary syndrome
percutaneous coronary intervention
antiplatelet therapy
st elevation myocardial infarction
st segment elevation myocardial infarction
peripheral blood
coronary artery disease
combination therapy
replacement therapy